7:00 am - 3:00 pm
Registration & Exhibits Open
The Registration Desk remains available throughout the day for attendee assistance, check-in, and conference information. Be sure to visit our industry partners throughout the prefunction space to discover the latest innovations, products, and resources supporting NET care.
7:00 am – 8:00 am
Satellite Symposium: Supported by ITM
Kick off the final day of the symposium by attending this industry-supported educational symposium presented by ITM. Breakfast will be served during the program. Additional educational content and faculty details will be shared as they are finalized.
8:05 am – 9:05 am
Explore some of the most challenging and evolving areas of neuroendocrine neoplasm (NEN) management through expert perspectives on complex clinical decision-making. This session examines contemporary approaches to liver transplantation, long-term considerations following radioligand therapy (RLT), treatment sequencing for pheochromocytoma and paraganglioma (PPGL), and advances in the management of functional NENs. Attendees will gain practical insights into navigating complex cases where emerging evidence continues to shape clinical practice, followed by audience discussion.
Liver Transplantation in NETs
Speaker TBD
Long Tail of PRRT: Understanding Therapy-Related Myeloid Malignancies with RLT
James A. Kennedy, MD PhD, FRCPC, Malignant Hematologist, Sunnybrook Health Sciences Centre; Assistant Professor, University of Toronto
PPGL: Treatment Sequencing
Sarimar Agosto Salgado, MD, Assistant Member, Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center
Updates in Management of Functional NENs
Maria Fleseriu, MD, FACE, Professor and Director OHSU Pituitary Center, Oregon Health & Science University
[Audience Discussion / Q&A]
NET MED 5: Complex Decisions and Evolving Treatment Paradigms
Moderator: Thomas Hope, MD, Professor, Radiology, University of California, San Francisco
10:25 am – 11:15 am
The symposium culminates with the 2026 NANETS Keynote Presentation featuring Halfdan Sorbye, MD, an internationally recognized leader in neuroendocrine tumor research and clinical care. Drawing on the latest evidence and global experience, Dr. Sorbye will provide expert insights into the management of extrapulmonary high-grade neuroendocrine neoplasms and discuss emerging strategies that are shaping the future of patient care.
[Audience Discussion / Q&A]
Keynote Presentation
Moderator: Simron Singh, MD, MPH, FRCPC, Professor, University of Toronto; Chair in Neuroendocrine Cancer Care , Temerty School of Medicine, University of Toronto; Provincial Head, Person Centered Care, Cancer Care Ontario; Medical Oncologist, Sunnybrook Odette Cancer Center/Susan Leslie Clinic for Neuroendocrine Cancers
Halfdan Sorbye, MD
Professor, Cancer Clinic, Haukeland University Hospital, Bergen, Norway
10:05 am – 10:20 am
Break
12:40 pm – 1:10 pm
Satellite Symposium: Supported by Boehringer Ingelheim
Take advantage of one final industry-supported educational opportunity before the symposium concludes. Complete program details, faculty, and session information will be shared as they become available.
2:30 pm – 3:30 pm
Conclude the symposium with an interactive multidisciplinary tumor board examining the management of oligometastatic neuroendocrine tumors through real-world clinical cases. Expert panelists representing surgical oncology, medical oncology, nuclear medicine, interventional radiology, endocrinology, and advanced practice will discuss diagnostic evaluation, treatment selection, and collaborative decision-making across two challenging case presentations. Audience participation is encouraged throughout this engaging discussion.
Case I: Average Small Bowel Low-Grade NET (Mesenteric Mass)
Seth J. Concors, MD, FACS, FSSO, Assistant Professor of Surgery, Division of Surgical Oncology, Emory University School of Medicine
Case II: Pancreatic Grade III NEN
Presenter TBD
Expert Panel
Rohit Thummalapalli, MD, Assistant Attending Physician, Memorial Sloan Kettering Cancer
Meghan A. Lilly, MD, Assistant Professor, Department of Radiology and Imaging Sciences, Emory University School of Medicine
Angela Laffan, NP, Assistant Director, Gastrointestinal Oncology Survivorship Program, University of California San Francisco
Additional Panelist to come!
[Audience Discussion / Q&A]
Tumor Board: Oligometastatic Disease Management
3:30 pm –3:45 pm
Closing Remarks
As the symposium concludes, NANETS President Simron Singh, MD, MPH, FRCPC, will offer closing reflections on the scientific discoveries, meaningful collaborations, and shared commitment that have defined this year's meeting. Join us as we celebrate the accomplishments of our community and look toward the future of neuroendocrine tumor care.
Saturday, November 7, 2026
1:35 pm – 2:25 pm
Artificial intelligence is rapidly transforming healthcare, offering new opportunities to enhance diagnosis, treatment planning, research, and patient care. This forward-looking session will explore the evolving role of AI in neuroendocrine tumor care through expert perspectives on emerging technologies, real-world applications, and the opportunities and challenges that lie ahead. Join us as we examine how AI may shape the future of precision medicine and multidisciplinary care for patients with NETs.
NET MED 7: AI in NET Care: Looking into the Future
Moderator: Renuka Iyer, MD,  Senior Vice President, Chief Medical Officer (CMO) at the National Comprehensive Cancer Network (NCCN)
9:05 am – 10:05 am
Annual Business Meeting & Awards Ceremony
Join NANETS President Simron Singh, MD, MPH, FRCPC, for the Society's Annual Business Meeting and Awards Ceremony. Learn about the organization's accomplishments, strategic initiatives, and future priorities while celebrating the outstanding individuals whose contributions have advanced neuroendocrine tumor research, education, advocacy, and patient care.
11:25 am – 12:25 pm
As advances in treatment continue to improve outcomes for patients with neuroendocrine neoplasms (NENs), optimizing quality of life has become an essential component of comprehensive care. This session explores practical strategies to support long-term survivorship, including patient-reported outcomes, palliative care integration, nutrition, and psychosocial well-being. Expert faculty will share approaches to helping patients not only live longer, but live better throughout every stage of their care.
Importance of PROs/QOL Assessments
Claire K. Mulvey, MD, Assistant Professor, University of California San Francisco
Palliative Care Integration Across the Care Continuum
Deirdre R. Pachman, MD, Palliative Care Specialist, Mayo Clinic
Nutrition (Post Surgery, Long-Term Well-Being)
Stephanie Moore, Senior Clinical Dietitian, MS, RD, CSO, CNSC, MD Anderson Cancer Center
Survivorship Care (Are You Aware of What Your Patients Are Talking About Outside of Clinic?)
Jessica Thomas, LCSW, Director of Patient Education, NETRF
[Audience Discussion / Q&A]
NET MED 6: Living Better While Living Longer with NENs
Moderator: Taymeyah Al-Toubah, MPH, Medical Student - MS1 (Italy)
12:25 pm – 1:30 pm
Lunch Available
Enjoy a complimentary lunch while connecting with colleagues and reflecting on the symposium's educational highlights. Lunch will be available throughout the hour. We encourage attendees to participate in the symposium's final Industry Satellite Symposium or take this opportunity to network and continue conversations before the closing scientific sessions.
4:00 pm –4:30 pm
NETCast | Symposium Wrap-Up
Be part of the live audience as NETCast concludes the symposium with reflections from faculty and invited guests. Together, they'll discuss the meeting's most impactful sessions, emerging trends, and what attendees can take back to their practices.
6:00 pm –9:00 pm
NANETS Board Meeting
Reserved for NANETS Board Members and invited guests, this meeting provides an opportunity to review Society business, discuss strategic initiatives, and plan for the continued advancement of NANETS' mission.